Stem cells, exosomes, gene therapy, peptides, hyperbaric oxygen, and epigenetic reprogramming
390 articoli
A new Nature Biotechnology review maps how large-scale AI foundation models are transforming biomedicine, from genomics to clinical diagnostics.
Scientists built the first in vitro menstrual cycle using organoids, uncovering WNT7A as a key driver of scarless endometrial regeneration.
Embryonic brain precursor cells grafted into adult rat striatum successfully integrate and reduce motor deficits in a Parkinson's disease model.
Vai oltre le basi per comprendere gli enzimi, le vie di segnalazione e il crosstalk cellulare che governano come invecchia la tua matrice extracellulare — e cosa stanno facendo i ricercatori al riguardo.
Next-gen CAR-T approaches skip the lab and engineer immune cells directly inside the body, potentially making cancer therapy faster and cheaper.
Scopri il framework invisibile che tiene insieme il tuo corpo — e perché mantenerlo in salute è una delle frontiere più entusiasmanti della scienza della longevità.
A comprehensive review reveals how biomaterials, stem cells, and 3D bioprinting are converging to restore damaged endometrial tissue and treat infertility.
Intellia's in vivo CRISPR treatment edits genes directly inside living patients and just cleared a Phase 3 trial — a world first.
Intellia Therapeutics reports a landmark Phase 3 win for CRISPR gene editing, potentially offering a one-time cure for a debilitating genetic disease.
Single-cell sequencing reveals ferroptosis drives pulpitis; thymosin α1 restores GPX4, cuts iron overload, and reduces inflammation in cells and rats.
Engineered immune cells simultaneously dissolve cardiac fibrosis and rebuild heart muscle in mice, offering a dual-action therapy for heart failure.
Scientists discover muscle cells bypass normal nuclear pores to export oversized RNA transcripts via a newly identified budding pathway.
